Soliqua 100/33
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0024-5761 -
Package NDC
0024-5761-01 -
Package NDC
0024-5761-05 -
Application number
BLA208673 -
SPL ID
dd3cca75-32f2-4e6d-8121-20f47e101495 -
SPL set ID
4bba538b-cf7c-4310-ae8f-cb711ed21bcc -
UNII
2ZM8CX04RZ -
UNII
74O62BB01U -
RxCUI
1858995 -
RxCUI
1859000
What the source publishes
- Labeler
- Sanofi-Aventis U.S. LLC
- Active ingredients
- insulin glargine and lixisenatide
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Soliqua 100/33",
"splId": "dd3cca75-32f2-4e6d-8121-20f47e101495",
"labels": [
{
"setId": "4bba538b-cf7c-4310-ae8f-cb711ed21bcc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4bba538b-cf7c-4310-ae8f-cb711ed21bcc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4bba538b-cf7c-4310-ae8f-cb711ed21bcc"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Sanofi-Aventis U.S. LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE in 1 CARTON (0024-5761-01) / 3 mL in 1 SYRINGE",
"package_ndc": "0024-5761-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20161121"
},
{
"sample": false,
"description": "5 SYRINGE in 1 CARTON (0024-5761-05) / 3 mL in 1 SYRINGE (0024-5761-02)",
"package_ndc": "0024-5761-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20161121"
}
],
"productId": "0024-5761_dd3cca75-32f2-4e6d-8121-20f47e101495",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0024-5761",
"deaSchedule": null,
"genericName": "insulin glargine and lixisenatide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INSULIN GLARGINE",
"strength": "100 U/mL"
},
{
"name": "LIXISENATIDE",
"strength": "33 ug/mL"
}
],
"applicationNumber": "BLA208673",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20161121",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0011417",
"N0000175453",
"N0000178480",
"M0160181",
"N0000020058"
],
"unii": [
"2ZM8CX04RZ",
"74O62BB01U"
],
"rxcui": [
"1858995",
"1859000"
],
"spl_set_id": [
"4bba538b-cf7c-4310-ae8f-cb711ed21bcc"
],
"pharm_class_cs": [
"Insulin [CS]",
"Glucagon-Like Peptide 1 [CS]"
],
"pharm_class_epc": [
"Insulin Analog [EPC]",
"GLP-1 Receptor Agonist [EPC]"
],
"pharm_class_moa": [
"Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
],
"manufacturer_name": [
"Sanofi-Aventis U.S. LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0024-5761_dd3cca75-32f2-4e6d-8121-20f47e101495"